Skip to main content
NCBI home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1989 Sep;80(9):848–854. doi: 10.1111/j.1349-7006.1989.tb01725.x

Hematologic and Cytogenetic Findings in Myelodysplastic Syndromes Treated with Recombinant Human Granulocyte Colony‐stimulating Factor

Kazuma Ohyashiki 1,✉, Junko H Ohyashiki 1, Keisuke Toyama 1, Fumimaro Takaku 2
PMCID: PMC5917852  PMID: 2480943

Abstract

We administered recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) to four patients with myelodysplastic syndrome (MDS) and three patients with non‐MDS (two malignant lymphoma and one lung cancer) as a part of a phase II trial and analyzed the effects of rhG‐CSF on the neoplastic cells of MDS by performing sequential chromosome analyses on the bone marrow cells. A greater than 3‐fold increase in neutrophil count was observed in the MDS patients after rhG‐CSF infusions, whereas the number of blasts in the bone marrow did not increase and none of them progressed into the leukemic phase. After rhG‐CSF treatment, the bone marrow cells obtained from patients without MDS did not show any particular chromosome abnormalities such as chromosomal breakage. On the contrary, two of the four MDS patients with acquired chromosome abnormalities showed a change in the frequency of marrow cells with clonal abnormalities after rhG‐CSF treatment; the proportion of metaphase cells with additional numerical chromosome abnormalities decreased in these two MDS patients. After discontinuation of the treatment, the constitution of marrow cells with chromosome changes reverted to that before treatment. The remaining two MDS patients did not show any particular chromosome changes after the rhG‐CSF treatment, indicating that rhG‐CSF may not promote the characteristics of dyshematopoiesis in MDS, and act on cells derived from an MDS clone

.

Keywords: Granulocyte colony‐stimulating factor, Myelodysplastic syndrome, Chromosome aberration

Full Text

The Full Text of this article is available as a PDF (425.1 KB).

REFERENCES

  • 1. ) Metcalf , D.The granulomacrophage colony‐stimulating factors . Science , 229 , 16 – 22 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Metcalf , D.The molecular biology and functions of the granulocyte‐macrophage colony‐stimulating factors . Blood , 67 , 257 – 267 ( 1986. ). [PubMed] [Google Scholar]
  • 3. ) Wong , G. G. , Witek , J. A. , Temple , P. A. , Wilkens , K. M. , Leary , A. C. , Luxenberg , D. P. , Jones , S. S. , Brown , E. L. , Kay , R. M. , Orr , E. C. , Shoemaker , C. , Golde , D. W. , Kaufman , R. J. , Hewick , R. M. , Wang , E. A. and Clark , S. C.Human GM‐CSF: molecular cloning of the complementary DNA and purification of the natural and recom‐binant proteins . Science , 228 , 810 – 815 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Nagata , S. , Tsuchiya , M. , Asano , S. , Kaziro , Y. , Yamazaki , T. , Yamamoto , O. , Hirata , Y. , Kubota , N. , Oheda , M. , Nomura , H. and Ono , M.Molecular cloning and expression of cDNA for human granulocyte colony stimulating factor . Nature , 319 , 415 – 418 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Jacobs , K. , Shoemaker , C. , Rudersdorf , R. , Neill , S. D. , Kaufman , R. J. , Mufson , A. , Seehra , J. , Jones , S. S. , Hewick , R. , Fritsch , E. F. , Kawakita , M. , Shimizu , T. and Miyake , T.Isolation and characterization of genomic and cDNA clones of human erythropoietin . Nature , 313 , 806 – 810 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 6. ) Vadhan‐Raj , S. , Keating , M. , LeMaistre , A. , Hittelman , W. N. , McCredie , K. , Trujillo , J. M. , Broxmeyer , H. E. , Henney , C. and Gutterman , J. U.Effects of recombinant human granulocyte‐macrophage colony‐stimulating factor in patients with myelodysplastic sydromes . N. Engl. J. Med. , 317 , 1545 – 1552 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 7. ) Vadhan‐Raj , S. , Hittelman , W. N. , Ventura , C. , Buescher , D. , Keating , M. J. and Gutterman , J. U.Granulocyte‐macrophage colony‐stimulating factor and mylodysplastic syndromes . N. Engl. J. Med. , 319 , 51 – 53 ( 1988. ). 3288869 [Google Scholar]
  • 8. ) Antin , J. H. , Smith , B. R. , Holmes , W. and Rosenthal , D. S.Phase I/II study of recombinant human granulocyte‐macrophage colony‐stimulating factor in aplastic anemia and myelodysplastic syndrome . Blood , 72 , 705 – 713 ( 1988. ). [PubMed] [Google Scholar]
  • 9. ) Ganser , A. , Volkers , B. , Greher , J. , Ottmann , O. G. , Walther , F. , Becher , R. , Bergmann , L. , Schulz , G. and Hoelzer , D.Recombinant human granulocyte‐macro phage colony‐stimulating factor in patients with myelodysplastic syndromes—a phase I/II trial . Blood , 73 , 31 – 37 ( 1989. ). [PubMed] [Google Scholar]
  • 10. ) Souza , L. M. , Boone , T. C. , Gabrilove , J. , Lai , P. H. , Zsebo , K. M. , Murdock , D. C. , Chazin , V. R. , Bruszewski , J. , Lu , H. , Chen , K. K. , Barendt , J. , Platzer , E. , Moore , M. A. S. , Mertelsman , R. and Welte , K.Recombinant human granulocyte colony‐stimulating factor: effects on normal and leukemic myeloid cells . Science , 232 , 61 – 65 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Welte , K. , Bonilla , M. A. , Gillio , A. P. , Boone , T. C. , Potter , G. C. , Gabrilove , J. L. , Moore , M. A. S. , O'Reilly , R. J. and Souza , L. M.Recombinant human granulocyte colony‐stimulating factor. Effects on hematopoisis in normal and cyclophosphamide‐treated primates . J. Exp. Med. , 165 , 941 – 948 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. ) Welte , K. , Bonilla , M. A. , Gabrilove , J. L. , Gillio , A. P , Potter , G. K. , Moore , M. A. S. , O'Reilly , R. J. , Boone , T. C. and Souza , L. M.Recombinant human granulocyte colony‐stimulating factor: in vitro and in vivo effects on myelopoiesis . Blood Cells , 13 , 17 – 30 ( 1987. ). [PubMed] [Google Scholar]
  • 13. ) Cohen , A. M. , Zsebo , K. M. , Inoue , H. , Hines , D. , Boone , T. C. , Chazin , V. R. , Tsai , L. , Ritch , T. and Souza , L. M.In vitro stimulation of granulocyte colony‐stimulation factor . Proc. Natl Acad. Sci USA , 84 , 2482 – 2488 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. ) Asano , S. and Ono , M.Human granulocyte colony‐stimulating factor: its biological action and clinical implication . Acta Heamatol. Jpn. , 50 , 1550 – 1556 ( 1987. ). [PubMed] [Google Scholar]
  • 15. ) Kobayashi , Y. , Okabe , T. , Ozawa , K. , Chiba , S. , Hino , M. , Miyazono , K. , Urabe , A. and Takaku , F.Treatment of myelodysplastic syndromes with recombinant human granulocyte colony‐stimulating factor: a preliminary report . Am. J. Med. , 86 , 178 – 182 ( 1989. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Bennett , J. M. , Catovsky , D. , Daniel , M. T. , Flandrin , G. , Gallon , D. A. G. , Gralnick , H. R. and Sultan , C.Proposals for the classification of the myelodysplastic syndromes . Br. J. Haematol. , 51 , 189 – 199 ( 1982. ). [PubMed] [Google Scholar]
  • 17. ) Toyama , K. , Ohyashiki , K. , Ohyashiki , J. H. and Takaku , F.Morphologic changes of neutrophils in myelodysplastic syndrome treated with recombinant human granulocyte colony‐stimulating factor . Jpn, J. Cancer Res. , 79 , 813 – 816 ( 1988. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Yoshida , M. C. , Ikeuchi , T. and Sasaki , M.Differential staining of parental chromosomes in interspecific cell hybrids with a combined quinacrine and Hoechst 33258 technique . Proc. Jpn. Acad. , 51 , 184 – 187 ( 1975. ). [Google Scholar]
  • 19. ) Report of the Standing Committee on Human Cytogenetic Nomenclature: ISCN 1985 . “ An International System for Human Cytogenetic Nomenclature ,“ ed. Harnden D. G. and Klinger H. P. , Cytogenet. Cell Genet. ( 1985. ). Karger; , Basel ). [Google Scholar]
  • 20. ) Yuo , A. , Kitagawa , S. , Okabe , T. , Urabe , A. , Komatsu , Y. , Itoh , S. and Takaku , F.Recombinant human granulo‐cyte colony‐stimulating factor repairs the abnormalities of neutrophils in patients with myelodysplastic syndromes and chronic myelogenous leukemia . Blood , 70 , 404 – 411 ( 1987. ). [PubMed] [Google Scholar]
  • 21. ) Mayani , H. , Baines , P. , Bowen , D. T. and Jacobs , A.In vitro growth of myeloid and erythroid progenitor cells from myelodysplastic patients in response to recombinant human granulocyte‐macrophage colony‐stimulating factor . Leukemia , 3 , 29 – 32 ( 1989. ). [PubMed] [Google Scholar]
  • 22. ) Wong , J. M. , Chen , Z. G. , Colella , S. , Bonilla , M. A. , Welte , K. , Bordignon , C. and Mantovani , A.Chemotactic activity of recombinant human granulocyte colony‐stimulating factor . Blood , 72 , 1456 – 1460 ( 1989. ). [PubMed] [Google Scholar]
  • 23. ) Raskind , W. H. , Tirumali , N. , Jacobson , R. , Singer , J. and Fialkow , P.Evidence for a multistep pathogenesis of a myelodysplastic syndrome . Blood , 63 , 1318 – 1323 ( 1984. ). [PubMed] [Google Scholar]
  • 24. ) Russell , N. H. and Reilly , A. G.Role of autocrine growth factors in the leukemic transformation of the myelodysplastic syndromes . Leukemia , 3 , 83 – 84 ( 1989. ). [PubMed] [Google Scholar]
  • 25. ) Mufti , G. J. and Galton , D. A. G.Myelodysplastic syndromes: natural history and features of prognostic importance . Clin. Haematol. , 15 , 953 – 973 ( 1986. ). [PubMed] [Google Scholar]
  • 26. ) Kelleher , C. , Miyauchi , J , Wong , G , Clark , S. , Minden , M. D. and MuCulloch , E. A.Synergism between recombinant growth factors, GM‐CSF and G‐CSF, acting on the blast cells of acute myeloblastic leukemia . Blood , 69 , 1498 – 1503 ( 1987. ). [PubMed] [Google Scholar]
  • 27. ) Nara , N. , Murohashi , I. , Suzuki , T. , Yamashita , Y. , Maruyama , Y. , Aoki , N. , Tanikawa , S. and Onozawa , Y.Effects of recombinant human granulocyte colony‐stimulating factor (G‐CSF) on blasts progenitors from acute myeloblastic leukaemia patients . Br, J. Cancer , 56 , 49 – 51 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28. ) Vellenga , E. , Young , D. C. , Wagner , K. , Wiper , D. , Ostapovicz , D. and Griffin , J. D.The effects of GM‐CSF and G‐CSF in promoting growth of clonogenic cells in acute myeloblastic leukemia . Blood , 69 , 1771 – 1776 ( 1987. ). [PubMed] [Google Scholar]
  • 29. ) Pierre , R. V.Cytogenetic studies in preleukemia: studies before and after transition to acute leukemia in 17 subjects . Blood Cells , 1 , 163 – 170 ( 1976. ). [Google Scholar]
  • 30. ) Benitez , J. , Carbonell , F. , Sanchez Fayos , J. and Heimpel , H.Karyotypic evolution in patients with myelodysplastic syndromes . Cancer Genet. Cytogenet. , 16 , 157 – 167 ( 1985. ). [DOI] [PubMed] [Google Scholar]
  • 31. ) Tricot , G. , Mecucci , C. and Van den Berghe , H.Evolution of the myelodysplastic syndromes . Br. J. Haematol , 63 , 609 – 614 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 32. ) Mecucci , C. , Rege‐Cambrin , G. , Michaux , J. L. , Tricot , G. and Van den Berghe , H.Multiple chromosomally distinct cell populations in myelodysplastic syndromes and their possible significance in the evolution of the disease . Br. J. Haematol. , 64 , 699 – 706 ( 1986. ). [DOI] [PubMed] [Google Scholar]
  • 33. ) Tricot , G. , Boogaerts , M. A. , Wolf‐Peeters , C. , Van den Berghe , H. and Verwilghen , R. L.The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations . Br. J. Haematol. , 59 , 659 – 670 ( 1985. ). [DOI] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES